Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Condensed Consolidated Statements of Operations and Comprehensive Loss [Abstract]    
Sales $ 22,065,424 $ 231,868
Cost of sales 14,059,109 166,160
Gross profit 8,006,315 65,708
Operating expenses:    
Selling, general and administrative expenses 8,062,123 273,750
Amortization expense 1,266,698 357,463
Transaction costs 2,020 968,505
Fair value remeasurement of SUNation earnout consideration 825,000  
Total operating expenses 10,155,841 1,599,718
Operating loss (2,149,526) (1,534,010)
Other income (expense):    
Investment and other income (expense) 19,533 (5,144)
Gain on sale of assets 244,271  
Fair value remeasurement of contingent value rights (250,000)  
Interest and other expense (458,218) (350,382)
Other expense, net (444,414) (355,526)
Net loss before income taxes (2,593,940) (1,889,536)
Income tax expense 5,732
Net loss from continuing operations (2,599,672) (1,889,536)
Net income from discontinued operations, net of tax 44,683 5,902
Net loss (2,554,989) (1,883,634)
Other comprehensive gain (loss), net of tax:    
Unrealized gain (loss) on available-for-sale securities 24,405 (17,067)
Total other comprehensive gain (loss) 24,405 (17,067)
Comprehensive loss $ (2,530,584) $ (1,900,701)
Basic net loss per share:    
Continuing operations $ (0.26) $ (0.58)
Basic net loss per share (0.26) (0.58)
Diluted net loss per share:    
Continuing operations (0.26) (0.58)
Diluted net loss per share $ (0.26) $ (0.58)
Weighted Average Basic Shares Outstanding 9,919,650 3,231,461
Weighted Average Dilutive Shares Outstanding 9,919,650 3,231,461